Search

Your search keyword '"Mathe G"' showing total 2,278 results

Search Constraints

Start Over You searched for: Author "Mathe G" Remove constraint Author: "Mathe G"
2,278 results on '"Mathe G"'

Search Results

9. Emerging Immunologic Approaches, to Treatment of Neoplastic Diseases

10. Follow-Up Results from a Randomized Trial for T3 and T4 Breast Cancer Patients: Previous BCG Immunotherapy Improves Response to Chemotherapy in the Relapse Patient

11. Chemotherapy of Carcinomas of the Digestive Tract

12. An Intensive Chemo- or Chemoimmunotherapy Regimen for Patients with Intermediate and Poor-Prognosis Acute Lymphatic Leukemia and Leukemic Lymphoblastic Lymphosarcoma: Preliminary Results with 14-Month Median Follow-Up

13. Tumor-Necrotizing Serum Production by Administration of BCG + Pseudomonas: Its Application in Treatment of Fibrosarcoma in Mice

14. Progress in Experimental Systemic Active Immunotherapy of Cancer

15. In Vivo Immunomodulating Properties of Two Synthetic Agents: Azimexon and Tuftsin

16. Correction of Immunodeficiency in Aged Mice by Levamisole and Bestatin Administration

17. Cisplatinumdiamminodichloride (CPDD) in Chemotherapy of Cancers: A Phase II Therapeutic Trial

18. Ultrastructural Study of the Cardiotoxicity and Light-Microscopic Findings of the Skin After Treatment of Golden Hamsters with Seven Different Anthracyclines

19. Phase II Trial of Aclacinomycin in Acute Leukemia and Lymphosarcoma

20. Preclinical and Phase I Studies of Malonatoplatinum

21. Vindesine: A New Vinca Alkaloid

22. Attempt at Immunotherapy With Living BCG in Patients With Bronchus Carcinoma

23. Results of a Randomized Trial of Prophylactic Chemotherapy in T3-T4 Breast Cancer Patients Previously Treated by Radiotherapy

24. Third Generation of Systemic Adjuvants of Immunity: Experimental Basis for Adjuvant Combinations

25. Some New Chemotherapeutic Agents and Combinations Possibly Available for New Adjuvant Therapies of Minimal Disease

26. Post-Surgical Systematic Active Immunotherapy: Rational and Experimental Basis

27. Dynamic and Composition of Cellular Membranes and Serum Lipids in Malignant Disorders

28. Preliminary Results of Chemoradiotherapy Followed (or Not) by Active Immunotherapy of Stage III and IV Lymphosarcoma and Reticulosarcoma: Correlation of the Results with WHO Categorization

29. Leukemic (or Stage V) Lymphosarcoma

30. Prognostic Factors and Treatment of Multiple Myeloma: Interest of a Cyclic Sequential Chemohormonotherapy Combining Cyclophosphamide, Melphalan, and Prednisone

31. Categorization of Non-Hodgkin’s Hematosarcomas (Lymphomas) According to T- and B-Cell Markers: Its Value for Diagnosis and Prognosis

32. Integration of Modern Data in WHO Categorization of Lymphosarcomas. Its Value for Prognosis Prediction and Therapeutic Adaptation to Prognosis

33. Treatment of Murine EAkR Lymphosarcoma by Surgery Combined With Systemic or Local Active BCG Immunotherapy Applied Repeatedly

34. Trial of BCG Immunotherapy in the Treatment of Resectable Squamous Cell Carcinoma of the Bronchus (Stages I and II)

35. Treatment by Radiophosphorus Versus Busulfan in Polycythemia Vera: A Randomized Trial (E.O.R.T.C.’s) 'Leukemias and Hematosarcomas' Group

36. Results in Children of Acute Lymphoid Leukemia: Protocol ICIG-ALL 9 Consisting of Chemotherapy for Only 9 Months Followed by Active Immunotherapy

37. Interspersion of Cyclophosphamide and BCG in the Treatment of L1210 Leukemia and Lewis Tumor

38. Treatment of Malignant Gliomas and Brain Metastases in Adults Using a Combination of Adriamycine, VM 26, and CCNU Results of a Type II Trial

39. Effectiveness of Murine Leukemia Chemotherapy According to the Immune State: Reconsideration of Correlations Between Chemotherapy, Tumour Cell Killing, and Survival Time

40. Non-Hodgkin’s Hematosarcoma ('Lymphomas'): Classification of the W. H. O. Reference Center for Neoplastic Disease of Hemopoietic and Lymphoid Tissues

41. Search for Correlations Between Immunological and Morphological Criteria Used to Classify Lymphoid Leukemias and Non-Hodgkin’s Hematosarcomas with Special Reference to Scanning Electron Microscopy and T and B Membrane Markers

42. An Immunological Classification of Leukemias and Hematosarcomas Based on Cell Membrane Markers with Special Reference to Null Cell Disorders

43. A Study of Viral Infections in Patients Treated with a Combination of 6 Mercaptopurine-Methotrexate: Preliminary Results

44. Prevention of Chemotherapy Complications: Time, Toxicity, Pharmacokinetic, Pharmacodynamic and Logistic Factors

45. Malignancies Possibly Secondary to Anticancer Therapy

46. Immune Responsiveness in Acute Lymphocytic Leukemia Patients under Chemotherapy and Immunotherapy: A Preliminary Report

47. Attempts at Immunotherapy of 100 Acute Lymphoid Leukemia Patients: Some Factors Influencing Results

48. Active Immunotherapy of AKR Mouse Spontaneous Leukemia

49. Experimental Screening for 'Systemic Adjuvants of Immunity' Applicable in Cancer Immunotherapy

50. Nonspecific Immune Responses in Hematosarcomas and Acute Leukemias

Catalog

Books, media, physical & digital resources